✦ LIBER ✦

Ximelagatran and melagatran compared with dalteparin for prevention of venous thromboembolism after total hip or knee replacement: the METHRO II randomised trial

✍ Scribed by Bengt I Eriksson; Peter Kälebo; David Bergqvisty; Ola E Dahl; Siv Lindbratt; Anders Bylock; Lars Frison; UG Eriksson; Lennart Welin; David Gustafsson

Book ID: 117282062
Publisher: The Lancet
Year: 2002
Tongue: English
Weight: 108 KB
Volume: 360
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(02)11469-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The direct thrombin inhibitor melagatran

The direct thrombin inhibitor melagatran followed by oral ximelagatran compared with enoxaparin for the prevention of venous thromboembolism after total hip or knee replacement: the EXPRESS study

✍ B. I. Eriksson; G. Agnelli; A. T. Cohen; O. E. Dahl; M. R. Lassen; P. Mouret; N. 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB

A phase II study of the oral factor Xa i

A phase II study of the oral factor Xa inhibitor LY517717 for the prevention of venous thromboembolism after hip or knee replacement

✍ G. AGNELLI; S. HAAS; J. S. GINSBERG; K. A. KRUEGER; A. DMITRIENKO; J. T. BRANDT 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 533 KB

A new oral direct thrombin inhibitor, da

A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial

✍ B. I. ERIKSSON; O. E. DAHL; H. R. BÜLLER; R. HETTIARACHCHI; N. ROSENCHER; M-L. B 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB